 | • レポートコード：QYR2104Z3455 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、159ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、肝疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法薬、標的療法、抗ウイルス薬、免疫グロブリン、コルチコステロイド、ワクチン、抗拒絶薬/免疫抑制剤）、用途別市場規模（がん、肝炎、肝硬変症、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肝疾患治療の市場動向 ・企業の競争状況、市場シェア ・肝疾患治療の種類別市場規模（化学療法薬、標的療法、抗ウイルス薬、免疫グロブリン、コルチコステロイド、ワクチン、抗拒絶薬/免疫抑制剤） ・肝疾患治療の用途別市場規模（がん、肝炎、肝硬変症、その他） ・肝疾患治療の北米市場規模2016-2027（アメリカ、カナダ） ・肝疾患治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肝疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肝疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・肝疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Bayer Schering、Eli Lilly、Merck、Novartis、Pfizer、Roche、Sanofi-Aventis、Takeda Pharmaceutical、Zydus Pharmaceuticals、Glaxosmithkline、Bristol-Myers Squibb、General Electric、Koninklijke Philips、Siemens、Canon Medical Systems Corp、Hitachi、Elekta、Neusoft Corporation、Samsung Healthcare、BPL Medical Technologies、Cura Healthcare、Angion Biomedica、Achillion Pharmaceuticals、Gilead Sciences、LG Life Sciences、Verva Pharmaceuticals、Shenzhen Kangtai Biological Products、Raptor Pharmaceuticals、ProMetic Life Sciences、Phenex Pharmaceuticals） ・結論 |
Liver disease, greenish-yellow or greenish-brown skin, often due to intrahepatic cholestasis, intrahepatic or extrahepatic biliary obstruction.The sex hormone secreted in liver disease cannot degrade and inactivate in time, which leads to hyperemia and dilatation of superficial arterioles.
Market Analysis and Insights: Global Liver Diseases Treatment Market
The global Liver Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Liver Diseases Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Liver Diseases Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Liver Diseases Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Liver Diseases Treatment market.
Global Liver Diseases Treatment Scope and Market Size
Liver Diseases Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liver Diseases Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy Drugs
Targeted Therapy
Anti-Viral Drugs
Immunoglobulins
Corticosteroids
Vaccines
Anti-Rejection Drugs/Immunosuppressant
Segment by Application
Cancer
Hepatitis
Cirrhosis
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Bayer Schering
Eli Lilly
Merck
Novartis
Pfizer
Roche
Sanofi-Aventis
Takeda Pharmaceutical
Merck
Novartis
Bristol-Myers Squibb
General Electric
Koninklijke Philips
Siemens
Canon Medical Systems Corp
Hitachi
Elekta
Neusoft Corporation
Samsung Healthcare
BPL Medical Technologies
Cura Healthcare
Angion Biomedica
Achillion Pharmaceuticals
Gilead Sciences
LG Life Sciences
Verva Pharmaceuticals
Shenzhen Kangtai Biological Products
Raptor Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Diseases Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy Drugs
1.2.3 Targeted Therapy
1.2.4 Anti-Viral Drugs
1.2.5 Immunoglobulins
1.2.6 Corticosteroids
1.2.7 Vaccines
1.2.8 Anti-Rejection Drugs/Immunosuppressant
1.3 Market by Application
1.3.1 Global Liver Diseases Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Hepatitis
1.3.4 Cirrhosis
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Liver Diseases Treatment Market Perspective (2016-2027)
2.2 Liver Diseases Treatment Growth Trends by Regions
2.2.1 Liver Diseases Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Liver Diseases Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Liver Diseases Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Liver Diseases Treatment Industry Dynamic
2.3.1 Liver Diseases Treatment Market Trends
2.3.2 Liver Diseases Treatment Market Drivers
2.3.3 Liver Diseases Treatment Market Challenges
2.3.4 Liver Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Diseases Treatment Players by Revenue
3.1.1 Global Top Liver Diseases Treatment Players by Revenue (2016-2021)
3.1.2 Global Liver Diseases Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Liver Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Liver Diseases Treatment Revenue
3.4 Global Liver Diseases Treatment Market Concentration Ratio
3.4.1 Global Liver Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Diseases Treatment Revenue in 2020
3.5 Liver Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Liver Diseases Treatment Product Solution and Service
3.7 Date of Enter into Liver Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Diseases Treatment Breakdown Data by Type
4.1 Global Liver Diseases Treatment Historic Market Size by Type (2016-2021)
4.2 Global Liver Diseases Treatment Forecasted Market Size by Type (2022-2027)
5 Liver Diseases Treatment Breakdown Data by Application
5.1 Global Liver Diseases Treatment Historic Market Size by Application (2016-2021)
5.2 Global Liver Diseases Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Liver Diseases Treatment Market Size (2016-2027)
6.2 North America Liver Diseases Treatment Market Size by Type
6.2.1 North America Liver Diseases Treatment Market Size by Type (2016-2021)
6.2.2 North America Liver Diseases Treatment Market Size by Type (2022-2027)
6.2.3 North America Liver Diseases Treatment Market Size by Type (2016-2027)
6.3 North America Liver Diseases Treatment Market Size by Application
6.3.1 North America Liver Diseases Treatment Market Size by Application (2016-2021)
6.3.2 North America Liver Diseases Treatment Market Size by Application (2022-2027)
6.3.3 North America Liver Diseases Treatment Market Size by Application (2016-2027)
6.4 North America Liver Diseases Treatment Market Size by Country
6.4.1 North America Liver Diseases Treatment Market Size by Country (2016-2021)
6.4.2 North America Liver Diseases Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Liver Diseases Treatment Market Size (2016-2027)
7.2 Europe Liver Diseases Treatment Market Size by Type
7.2.1 Europe Liver Diseases Treatment Market Size by Type (2016-2021)
7.2.2 Europe Liver Diseases Treatment Market Size by Type (2022-2027)
7.2.3 Europe Liver Diseases Treatment Market Size by Type (2016-2027)
7.3 Europe Liver Diseases Treatment Market Size by Application
7.3.1 Europe Liver Diseases Treatment Market Size by Application (2016-2021)
7.3.2 Europe Liver Diseases Treatment Market Size by Application (2022-2027)
7.3.3 Europe Liver Diseases Treatment Market Size by Application (2016-2027)
7.4 Europe Liver Diseases Treatment Market Size by Country
7.4.1 Europe Liver Diseases Treatment Market Size by Country (2016-2021)
7.4.2 Europe Liver Diseases Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Liver Diseases Treatment Market Size (2016-2027)
8.2 Asia-Pacific Liver Diseases Treatment Market Size by Type
8.2.1 Asia-Pacific Liver Diseases Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Liver Diseases Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Liver Diseases Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Liver Diseases Treatment Market Size by Application
8.3.1 Asia-Pacific Liver Diseases Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Liver Diseases Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Liver Diseases Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Liver Diseases Treatment Market Size by Region
8.4.1 Asia-Pacific Liver Diseases Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Liver Diseases Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Liver Diseases Treatment Market Size (2016-2027)
9.2 Latin America Liver Diseases Treatment Market Size by Type
9.2.1 Latin America Liver Diseases Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Liver Diseases Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Liver Diseases Treatment Market Size by Type (2016-2027)
9.3 Latin America Liver Diseases Treatment Market Size by Application
9.3.1 Latin America Liver Diseases Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Liver Diseases Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Liver Diseases Treatment Market Size by Application (2016-2027)
9.4 Latin America Liver Diseases Treatment Market Size by Country
9.4.1 Latin America Liver Diseases Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Liver Diseases Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Diseases Treatment Market Size (2016-2027)
10.2 Middle East & Africa Liver Diseases Treatment Market Size by Type
10.2.1 Middle East & Africa Liver Diseases Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Liver Diseases Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Liver Diseases Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Liver Diseases Treatment Market Size by Application
10.3.1 Middle East & Africa Liver Diseases Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Liver Diseases Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Liver Diseases Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Liver Diseases Treatment Market Size by Country
10.4.1 Middle East & Africa Liver Diseases Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Liver Diseases Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Liver Diseases Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Liver Diseases Treatment Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Bayer Schering
11.2.1 Bayer Schering Company Details
11.2.2 Bayer Schering Business Overview
11.2.3 Bayer Schering Liver Diseases Treatment Introduction
11.2.4 Bayer Schering Revenue in Liver Diseases Treatment Business (2016-2021)
11.2.5 Bayer Schering Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Liver Diseases Treatment Introduction
11.3.4 Eli Lilly Revenue in Liver Diseases Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Liver Diseases Treatment Introduction
11.4.4 Merck Revenue in Liver Diseases Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Liver Diseases Treatment Introduction
11.5.4 Novartis Revenue in Liver Diseases Treatment Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Liver Diseases Treatment Introduction
11.6.4 Pfizer Revenue in Liver Diseases Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Liver Diseases Treatment Introduction
11.7.4 Roche Revenue in Liver Diseases Treatment Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Sanofi-Aventis
11.8.1 Sanofi-Aventis Company Details
11.8.2 Sanofi-Aventis Business Overview
11.8.3 Sanofi-Aventis Liver Diseases Treatment Introduction
11.8.4 Sanofi-Aventis Revenue in Liver Diseases Treatment Business (2016-2021)
11.8.5 Sanofi-Aventis Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Details
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Liver Diseases Treatment Introduction
11.9.4 Takeda Pharmaceutical Revenue in Liver Diseases Treatment Business (2016-2021)
11.9.5 Takeda Pharmaceutical Recent Development
11.10 Zydus Pharmaceuticals
11.10.1 Zydus Pharmaceuticals Company Details
11.10.2 Zydus Pharmaceuticals Business Overview
11.10.3 Zydus Pharmaceuticals Liver Diseases Treatment Introduction
11.10.4 Zydus Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021)
11.10.5 Zydus Pharmaceuticals Recent Development
11.11 Glaxosmithkline
11.11.1 Glaxosmithkline Company Details
11.11.2 Glaxosmithkline Business Overview
11.11.3 Glaxosmithkline Liver Diseases Treatment Introduction
11.11.4 Glaxosmithkline Revenue in Liver Diseases Treatment Business (2016-2021)
11.11.5 Glaxosmithkline Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Liver Diseases Treatment Introduction
11.12.4 Bristol-Myers Squibb Revenue in Liver Diseases Treatment Business (2016-2021)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 General Electric
11.13.1 General Electric Company Details
11.13.2 General Electric Business Overview
11.13.3 General Electric Liver Diseases Treatment Introduction
11.13.4 General Electric Revenue in Liver Diseases Treatment Business (2016-2021)
11.13.5 General Electric Recent Development
11.14 Koninklijke Philips
11.14.1 Koninklijke Philips Company Details
11.14.2 Koninklijke Philips Business Overview
11.14.3 Koninklijke Philips Liver Diseases Treatment Introduction
11.14.4 Koninklijke Philips Revenue in Liver Diseases Treatment Business (2016-2021)
11.14.5 Koninklijke Philips Recent Development
11.15 Siemens
11.15.1 Siemens Company Details
11.15.2 Siemens Business Overview
11.15.3 Siemens Liver Diseases Treatment Introduction
11.15.4 Siemens Revenue in Liver Diseases Treatment Business (2016-2021)
11.15.5 Siemens Recent Development
11.16 Canon Medical Systems Corp
11.16.1 Canon Medical Systems Corp Company Details
11.16.2 Canon Medical Systems Corp Business Overview
11.16.3 Canon Medical Systems Corp Liver Diseases Treatment Introduction
11.16.4 Canon Medical Systems Corp Revenue in Liver Diseases Treatment Business (2016-2021)
11.16.5 Canon Medical Systems Corp Recent Development
11.17 Hitachi
11.17.1 Hitachi Company Details
11.17.2 Hitachi Business Overview
11.17.3 Hitachi Liver Diseases Treatment Introduction
11.17.4 Hitachi Revenue in Liver Diseases Treatment Business (2016-2021)
11.17.5 Hitachi Recent Development
11.18 Elekta
11.18.1 Elekta Company Details
11.18.2 Elekta Business Overview
11.18.3 Elekta Liver Diseases Treatment Introduction
11.18.4 Elekta Revenue in Liver Diseases Treatment Business (2016-2021)
11.18.5 Elekta Recent Development
11.18 Neusoft Corporation
11.25.1 Neusoft Corporation Company Details
11.25.2 Neusoft Corporation Business Overview
11.25.3 Neusoft Corporation Liver Diseases Treatment Introduction
11.25.4 Neusoft Corporation Revenue in Liver Diseases Treatment Business (2016-2021)
11.25.5 Neusoft Corporation Recent Development
11.20 Samsung Healthcare
11.20.1 Samsung Healthcare Company Details
11.20.2 Samsung Healthcare Business Overview
11.20.3 Samsung Healthcare Liver Diseases Treatment Introduction
11.20.4 Samsung Healthcare Revenue in Liver Diseases Treatment Business (2016-2021)
11.20.5 Samsung Healthcare Recent Development
11.21 BPL Medical Technologies
11.21.1 BPL Medical Technologies Company Details
11.21.2 BPL Medical Technologies Business Overview
11.21.3 BPL Medical Technologies Liver Diseases Treatment Introduction
11.21.4 BPL Medical Technologies Revenue in Liver Diseases Treatment Business (2016-2021)
11.21.5 BPL Medical Technologies Recent Development
11.22 Cura Healthcare
11.22.1 Cura Healthcare Company Details
11.22.2 Cura Healthcare Business Overview
11.22.3 Cura Healthcare Liver Diseases Treatment Introduction
11.22.4 Cura Healthcare Revenue in Liver Diseases Treatment Business (2016-2021)
11.22.5 Cura Healthcare Recent Development
11.23 Angion Biomedica
11.23.1 Angion Biomedica Company Details
11.23.2 Angion Biomedica Business Overview
11.23.3 Angion Biomedica Liver Diseases Treatment Introduction
11.23.4 Angion Biomedica Revenue in Liver Diseases Treatment Business (2016-2021)
11.23.5 Angion Biomedica Recent Development
11.24 Achillion Pharmaceuticals
11.24.1 Achillion Pharmaceuticals Company Details
11.24.2 Achillion Pharmaceuticals Business Overview
11.24.3 Achillion Pharmaceuticals Liver Diseases Treatment Introduction
11.24.4 Achillion Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021)
11.24.5 Achillion Pharmaceuticals Recent Development
11.25 Gilead Sciences
11.25.1 Gilead Sciences Company Details
11.25.2 Gilead Sciences Business Overview
11.25.3 Gilead Sciences Liver Diseases Treatment Introduction
11.25.4 Gilead Sciences Revenue in Liver Diseases Treatment Business (2016-2021)
11.25.5 Gilead Sciences Recent Development
11.26 LG Life Sciences
11.26.1 LG Life Sciences Company Details
11.26.2 LG Life Sciences Business Overview
11.26.3 LG Life Sciences Liver Diseases Treatment Introduction
11.26.4 LG Life Sciences Revenue in Liver Diseases Treatment Business (2016-2021)
11.26.5 LG Life Sciences Recent Development
11.27 Verva Pharmaceuticals
11.27.1 Verva Pharmaceuticals Company Details
11.27.2 Verva Pharmaceuticals Business Overview
11.27.3 Verva Pharmaceuticals Liver Diseases Treatment Introduction
11.27.4 Verva Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021)
11.27.5 Verva Pharmaceuticals Recent Development
11.28 Shenzhen Kangtai Biological Products
11.28.1 Shenzhen Kangtai Biological Products Company Details
11.28.2 Shenzhen Kangtai Biological Products Business Overview
11.28.3 Shenzhen Kangtai Biological Products Liver Diseases Treatment Introduction
11.28.4 Shenzhen Kangtai Biological Products Revenue in Liver Diseases Treatment Business (2016-2021)
11.28.5 Shenzhen Kangtai Biological Products Recent Development
11.29 Raptor Pharmaceuticals
11.29.1 Raptor Pharmaceuticals Company Details
11.29.2 Raptor Pharmaceuticals Business Overview
11.29.3 Raptor Pharmaceuticals Liver Diseases Treatment Introduction
11.29.4 Raptor Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021)
11.29.5 Raptor Pharmaceuticals Recent Development
11.30 ProMetic Life Sciences
11.30.1 ProMetic Life Sciences Company Details
11.30.2 ProMetic Life Sciences Business Overview
11.30.3 ProMetic Life Sciences Liver Diseases Treatment Introduction
11.30.4 ProMetic Life Sciences Revenue in Liver Diseases Treatment Business (2016-2021)
11.30.5 ProMetic Life Sciences Recent Development
11.31 Phenex Pharmaceuticals
11.31.1 Phenex Pharmaceuticals Company Details
11.31.2 Phenex Pharmaceuticals Business Overview
11.31.3 Phenex Pharmaceuticals Liver Diseases Treatment Introduction
11.31.4 Phenex Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021)
11.31.5 Phenex Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Liver Diseases Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy Drugs
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Anti-Viral Drugs
Table 5. Key Players of Immunoglobulins
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Vaccines
Table 8. Key Players of Anti-Rejection Drugs/Immunosuppressant
Table 9. Global Liver Diseases Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Liver Diseases Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Liver Diseases Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Liver Diseases Treatment Market Share by Regions (2016-2021)
Table 13. Global Liver Diseases Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Liver Diseases Treatment Market Share by Regions (2022-2027)
Table 15. Liver Diseases Treatment Market Trends
Table 16. Liver Diseases Treatment Market Drivers
Table 17. Liver Diseases Treatment Market Challenges
Table 18. Liver Diseases Treatment Market Restraints
Table 19. Global Liver Diseases Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Liver Diseases Treatment Market Share by Players (2016-2021)
Table 21. Global Top Liver Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Diseases Treatment as of 2020)
Table 22. Ranking of Global Top Liver Diseases Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Liver Diseases Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Liver Diseases Treatment Product Solution and Service
Table 26. Date of Enter into Liver Diseases Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Liver Diseases Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Liver Diseases Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Liver Diseases Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Liver Diseases Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Liver Diseases Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Liver Diseases Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Liver Diseases Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Liver Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Liver Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Liver Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Liver Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Liver Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Liver Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Liver Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Liver Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Liver Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Liver Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Liver Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Liver Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Liver Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Liver Diseases Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Liver Diseases Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Liver Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Liver Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Liver Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Liver Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Liver Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Liver Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Liver Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Liver Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Liver Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Liver Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Liver Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Liver Diseases Treatment Product
Table 69. Abbott Laboratories Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 70. Abbott Laboratories Recent Development
Table 71. Bayer Schering Company Details
Table 72. Bayer Schering Business Overview
Table 73. Bayer Schering Liver Diseases Treatment Product
Table 74. Bayer Schering Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 75. Bayer Schering Recent Development
Table 76. Eli Lilly Company Details
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Liver Diseases Treatment Product
Table 79. Eli Lilly Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 80. Eli Lilly Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Liver Diseases Treatment Product
Table 84. Merck Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 85. Merck Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Liver Diseases Treatment Product
Table 89. Novartis Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Liver Diseases Treatment Product
Table 94. Pfizer Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Liver Diseases Treatment Product
Table 99. Roche Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 100. Roche Recent Development
Table 101. Sanofi-Aventis Company Details
Table 102. Sanofi-Aventis Business Overview
Table 103. Sanofi-Aventis Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 104. Sanofi-Aventis Recent Development
Table 105. Takeda Pharmaceutical Company Details
Table 106. Takeda Pharmaceutical Business Overview
Table 107. Takeda Pharmaceutical Liver Diseases Treatment Product
Table 108. Takeda Pharmaceutical Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 109. Takeda Pharmaceutical Recent Development
Table 110. Zydus Pharmaceuticals Company Details
Table 111. Zydus Pharmaceuticals Business Overview
Table 112. Zydus Pharmaceuticals Liver Diseases Treatment Product
Table 113. Zydus Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 114. Zydus Pharmaceuticals Recent Development
Table 115. Glaxosmithkline Company Details
Table 116. Glaxosmithkline Business Overview
Table 117. Glaxosmithkline Liver Diseases Treatment Product
Table 118. Glaxosmithkline Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 119. Glaxosmithkline Recent Development
Table 120. Bristol-Myers Squibb Company Details
Table 121. Bristol-Myers Squibb Business Overview
Table 122. Bristol-Myers Squibb Liver Diseases Treatment Product
Table 123. Bristol-Myers Squibb Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 124. Bristol-Myers Squibb Recent Development
Table 125. General Electric Company Details
Table 126. General Electric Business Overview
Table 127. General Electric Liver Diseases Treatment Product
Table 128. General Electric Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 129. General Electric Recent Development
Table 130. Koninklijke Philips Company Details
Table 131. Koninklijke Philips Business Overview
Table 132. Koninklijke Philips Liver Diseases Treatment Product
Table 133. Koninklijke Philips Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 134. Koninklijke Philips Recent Development
Table 135. Siemens Company Details
Table 136. Siemens Business Overview
Table 137. Siemens Liver Diseases Treatment Product
Table 138. Siemens Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 139. Siemens Recent Development
Table 140. Canon Medical Systems Corp Company Details
Table 141. Canon Medical Systems Corp Business Overview
Table 142. Canon Medical Systems Corp Liver Diseases Treatment Product
Table 143. Canon Medical Systems Corp Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 144. Canon Medical Systems Corp Recent Development
Table 145. Hitachi Company Details
Table 146. Hitachi Business Overview
Table 147. Hitachi Liver Diseases Treatment Product
Table 148. Hitachi Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 149. Hitachi Recent Development
Table 150. Elekta Company Details
Table 151. Elekta Business Overview
Table 152. Elekta Liver Diseases Treatment Product
Table 153. Elekta Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 154. Elekta Recent Development
Table 155. Neusoft Corporation Company Details
Table 156. Neusoft Corporation Business Overview
Table 157. Neusoft Corporation Liver Diseases Treatment Product
Table 158. Neusoft Corporation Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 159. Neusoft Corporation Recent Development
Table 160. Samsung Healthcare Company Details
Table 161. Samsung Healthcare Business Overview
Table 162. Samsung Healthcare Liver Diseases Treatment Product
Table 163. Samsung Healthcare Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 164. Samsung Healthcare Recent Development
Table 165. BPL Medical Technologies Company Details
Table 166. BPL Medical Technologies Business Overview
Table 167. BPL Medical Technologies Liver Diseases Treatment Product
Table 168. BPL Medical Technologies Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 169. BPL Medical Technologies Recent Development
Table 170. Cura Healthcare Company Details
Table 171. Cura Healthcare Business Overview
Table 172. Cura Healthcare Liver Diseases Treatment Product
Table 173. Cura Healthcare Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 174. Cura Healthcare Recent Development
Table 175. Angion Biomedica Company Details
Table 176. Angion Biomedica Business Overview
Table 177. Angion Biomedica Liver Diseases Treatment Product
Table 178. Angion Biomedica Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 179. Angion Biomedica Recent Development
Table 180. Achillion Pharmaceuticals Company Details
Table 181. Achillion Pharmaceuticals Business Overview
Table 182. Achillion Pharmaceuticals Liver Diseases TreatmentProduct
Table 183. Achillion Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 184. Achillion Pharmaceuticals Recent Development
Table 185. Gilead Sciences Company Details
Table 186. Gilead Sciences Business Overview
Table 187. Gilead Sciences Liver Diseases Treatment Product
Table 188. Gilead Sciences Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 189. Gilead Sciences Recent Development
Table 190. LG Life Sciences Company Details
Table 191. LG Life Sciences Business Overview
Table 192. LG Life Sciences Liver Diseases Treatment Product
Table 193. LG Life Sciences Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 194. LG Life Sciences Recent Development
Table 195. Verva Pharmaceuticals Company Details
Table 196. Verva Pharmaceuticals Business Overview
Table 197. Verva Pharmaceuticals Liver Diseases Treatment Product
Table 198. Verva Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 199. Verva Pharmaceuticals Recent Development
Table 200. Shenzhen Kangtai Biological Products Company Details
Table 201. Shenzhen Kangtai Biological Products Business Overview
Table 202. Shenzhen Kangtai Biological Products Liver Diseases Treatment Product
Table 203. Shenzhen Kangtai Biological Products Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 204. Shenzhen Kangtai Biological Products Recent Development
Table 205. Raptor Pharmaceuticals Company Details
Table 206. Raptor Pharmaceuticals Business Overview
Table 207. Raptor Pharmaceuticals Liver Diseases Treatment Product
Table 208. Raptor Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 209. Raptor Pharmaceuticals Recent Development
Table 210. ProMetic Life Sciences Company Details
Table 211. ProMetic Life Sciences Business Overview
Table 212. ProMetic Life Sciences Liver Diseases Treatment Product
Table 213. ProMetic Life Sciences Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 214. ProMetic Life Sciences Recent Development
Table 215. Phenex Pharmaceuticals Company Details
Table 216. Phenex Pharmaceuticals Business Overview
Table 217. Phenex Pharmaceuticals Liver Diseases Treatment Product
Table 218. Phenex Pharmaceuticals Revenue in Liver Diseases Treatment Business (2016-2021) & (US$ Million)
Table 219. Phenex Pharmaceuticals Recent Development
Table 220. Research Programs/Design for This Report
Table 221. Key Data Information from Secondary Sources
Table 222. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Diseases Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Drugs Features
Figure 3. Targeted Therapy Features
Figure 4. Anti-Viral Drugs Features
Figure 5. Immunoglobulins Features
Figure 6. Corticosteroids Features
Figure 7. Vaccines Features
Figure 8. Anti-Rejection Drugs/Immunosuppressant Features
Figure 9. Global Liver Diseases Treatment Market Share by Application: 2020 VS 2027
Figure 10. Cancer Case Studies
Figure 11. Hepatitis Case Studies
Figure 12. Cirrhosis Case Studies
Figure 13. Other Case Studies
Figure 14. Liver Diseases Treatment Report Years Considered
Figure 15. Global Liver Diseases Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Liver Diseases Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Liver Diseases Treatment Market Share by Regions: 2020 VS 2027
Figure 18. Global Liver Diseases Treatment Market Share by Regions (2022-2027)
Figure 19. Global Liver Diseases Treatment Market Share by Players in 2020
Figure 20. Global Top Liver Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Diseases Treatment as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Liver Diseases Treatment Revenue in 2020
Figure 22. Global Liver Diseases Treatment Revenue Market Share by Type (2016-2021)
Figure 23. Global Liver Diseases Treatment Revenue Market Share by Type (2022-2027)
Figure 24. North America Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Liver Diseases Treatment Market Share by Type (2016-2027)
Figure 26. North America Liver Diseases Treatment Market Share by Application (2016-2027)
Figure 27. North America Liver Diseases Treatment Market Share by Country (2016-2027)
Figure 28. United States Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Liver Diseases Treatment Market Share by Type (2016-2027)
Figure 32. Europe Liver Diseases Treatment Market Share by Application (2016-2027)
Figure 33. Europe Liver Diseases Treatment Market Share by Country (2016-2027)
Figure 34. Germany Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Liver Diseases Treatment Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Liver Diseases Treatment Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Liver Diseases Treatment Market Share by Region (2016-2027)
Figure 44. China Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Liver Diseases Treatment Market Share by Type (2016-2027)
Figure 52. Latin America Liver Diseases Treatment Market Share by Application (2016-2027)
Figure 53. Latin America Liver Diseases Treatment Market Share by Country (2016-2027)
Figure 54. Mexico Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Liver Diseases Treatment Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Liver Diseases Treatment Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Liver Diseases Treatment Market Share by Country (2016-2027)
Figure 60. Turkey Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Liver Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Abbott Laboratories Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 64. Bayer Schering Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 65. Eli Lilly Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 70. Sanofi-Aventis Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 71. Takeda Pharmaceutical Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 72. Zydus Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 73. Glaxosmithkline Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 74. Bristol-Myers Squibb Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 75. General Electric Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 76. Koninklijke Philips Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 77. Siemens Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 78. Canon Medical Systems Corp Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 79. Hitachi Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 80. Elekta Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 81. Neusoft Corporation Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 82. Samsung Healthcare Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 83. BPL Medical Technologies Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 84. Cura Healthcare Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 85. Angion Biomedica Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 86. Achillion Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 87. Gilead Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 88. LG Life Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 89. Verva Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 90. Shenzhen Kangtai Biological Products Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 91. Raptor Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 92. ProMetic Life Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 93. Phenex Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2016-2021)
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
世界の抗肝炎ウイルス薬市場規模・現状・予測（2021年-2027年） In 2019, the global antiviral drug market was approximately US$ 56.4 billion, while Anti-hepatitis virus drugs accounted for about 38%, closed to USD$ 21 billion. Market Analysis and Insights: Global Anti Hepatitis Virus Drugs Market The global Anti Hepatitis Virus Drugs market size is projected to …- 世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
- 世界の抗ウイルス薬市場 2021：企業別、地域別、種類・用途別 The Anti-Viral Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界の孤児肺疾患治療市場規模・現状・予測（2021年-2027年） Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists. Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are e…
- 世界のC型肝炎治療薬市場規模・現状・予測（2021年-2027年） Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc. Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepa…